(Q46670774)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Adalimumab for the treatment of inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

15 January 2020

main subject

adalimumab

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Sunanda V Kane

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Gastroenterology & Hepatology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

679-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

15 January 2020

cites work

1 reference

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

21 January 2018

1 reference

Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis

21 January 2018

1 reference

Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis

21 January 2018

1 reference

Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis

21 January 2018

1 reference

Tumor necrosis factor: biology and therapeutic inhibitors

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

21 January 2018

1 reference

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

21 January 2018

1 reference

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease

21 January 2018

1 reference

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

21 January 2018

1 reference

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

21 January 2018

1 reference

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

21 January 2018

1 reference

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial

21 January 2018

1 reference

Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease

21 January 2018

1 reference

Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review

21 January 2018

1 reference

Adalimumab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy.

21 January 2018

1 reference

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

21 January 2018

1 reference

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

21 January 2018

1 reference

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

21 January 2018

1 reference

Adherence to adalimumab therapy in Crohn's disease: a French multicenter experience.

21 January 2018

1 reference

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.11.81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017695%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference